Issue 19, 2013

Analysis of metformin, glimepiride and pioglitazone in human serum and its application to pharmacokinetics

Abstract

A robust method, for the chromatographic separation of three antidiabetic drugs viz metformin, pioglitazone and glimepiride using an isocratic reversed phase high-performance liquid chromatographic (HPLC) system having ultraviolet detection at 254 nm is presented in this paper. The method was developed in human serum and dosage formulation with high-quality chromatographic separation between the drug peaks by using a stainless steel analytical column Nucleosil, C18 (10 micron, 25 × 0.46 cm). The system was operated at room temperature using a mobile phase consisting of acetonitrile, phosphate buffer (pH 4.3) in the ratio of 60 : 40 v/v at a flow rate of 1 mL min−1. The parametric statistics, i.e., correlation coefficient of 0.999 was assessed for all the drugs having linearity over the tested concentration range (10 to 10 000 ng mL−1) in human serum. The accuracy and the relative standard deviations of samples for six replicate measurements were not less than 97% and greater than 2%, respectively. The proposed method was validated for selectivity, linearity, accuracy, and precision according to the International Conference on Harmonization (ICH). The method is applicable for the quality control of the mentioned drugs in raw material, bulk drug, and pharmaceutical formulations as well as in human serum.

Graphical abstract: Analysis of metformin, glimepiride and pioglitazone in human serum and its application to pharmacokinetics

Article information

Article type
Paper
Submitted
25 May 2013
Accepted
04 Jul 2013
First published
12 Aug 2013

Anal. Methods, 2013,5, 5096-5104

Analysis of metformin, glimepiride and pioglitazone in human serum and its application to pharmacokinetics

F. A. Siddiqui, N. Sher, A. Zubair, H. Shamshad, N. Shafi and A. Z. Mirza, Anal. Methods, 2013, 5, 5096 DOI: 10.1039/C3AY40884A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements